![](https://investorshub.advfn.com/uicon/48355.png?cb=1551739062)
Friday, May 06, 2022 10:38:10 AM
New York Yankees and Duke Basketball
Recent ACON News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:58:12 PM
- Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment Plans • GlobeNewswire Inc. • 08/21/2024 11:57:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:56:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2024 08:01:01 PM
- Aclarion to Present at August 20th Virtual Investor Summit Microcap Event • GlobeNewswire Inc. • 08/15/2024 01:48:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 07:34:17 PM
- Aclarion Announces First Commercial Agreement in Michigan • GlobeNewswire Inc. • 08/14/2024 12:08:00 PM
- Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK • GlobeNewswire Inc. • 08/13/2024 01:07:00 PM
- Form 253G3 - • Edgar (US Regulatory) • 08/13/2024 01:05:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/13/2024 11:56:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:02:13 PM
- Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK • GlobeNewswire Inc. • 07/09/2024 11:00:00 AM
- Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK • GlobeNewswire Inc. • 06/26/2024 12:30:00 PM
- Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London • GlobeNewswire Inc. • 06/25/2024 12:30:00 PM
- Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain • GlobeNewswire Inc. • 04/25/2024 01:14:37 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 03/06/2024 09:09:09 PM
- Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
- Aclarion Announces Closing of $3.0 Million Public Offering • GlobeNewswire Inc. • 02/27/2024 08:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 07:00:20 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/27/2024 03:46:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/27/2024 05:15:34 AM
- Aclarion Announces Pricing of $3.0 Million Public Offering • GlobeNewswire Inc. • 02/26/2024 02:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/23/2024 04:46:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:43 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/21/2024 08:02:48 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM